Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

GSK (GSK.L)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2021-01-2614101450Neutral
2021-02-0812701320Neutral
2021-04-1913381360Neutral
2021-05-1013521370Neutral
2021-07-0114381500Neutral
2021-08-0214281485Neutral
2021-08-2614791540Neutral
2021-09-2014041460Neutral
2021-11-0815581500Neutral
2021-12-0115411600Neutral
2022-01-1717081680Neutral
2022-04-1117841790Neutral
2022-06-0616951866Neutral
2022-07-0817551876Neutral
2022-07-1917831850Neutral
2022-07-2917281860Neutral
2022-08-0516671820Neutral
2022-11-1113241300Sell
2023-01-0914211245Sell
2023-03-0114221300Sell
2023-05-0514621310Sell
2024-01-1515801860Buy
2024-03-1916642040Buy

Disclosures

  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.